Publications by authors named "D J McCormick"
Objectives: Few opportunities exist for postgraduate physicians to learn to address racism in their professional practice. We created a virtual, 5-session antiracism course that included the development of a formal action project to address racism at participants' home institution.
Methods: We delivered this curriculum virtually to 2 cohorts (2021 and 2022) of postgraduate physicians, nationally.
Interleukin (IL)-33 is released following tissue damage, causing airway inflammation and remodelling via reduced IL-33 (IL-33)/serum stimulation-2 (ST2) and oxidised IL-33 (IL-33)/receptor for advanced glycation end products (RAGE)/epidermal growth factor receptor (EGFR) pathways. This study aimed to identify associations of IL-33 with clinical outcomes and pathological mechanisms during viral lower respiratory tract disease (LRTD). Ultra-sensitive immunoassays were developed to measure IL-33, IL-33 and IL-33/sST2 complexes in samples from patients hospitalised with COVID-19.
View Article and Find Full Text PDFObjective: Pet ownership among people experiencing homelessness (PEH) is common, but access to shelter, veterinary care, and flea-preventative products for PEH who own pets in the US is not well described. We sought to evaluate current knowledge of fleas and flea-borne diseases and characterize practices around pets and service animals among staff at homeless shelters and outreach organizations.
Methods: In-person surveys were administered to staff at homeless shelters and on outreach teams in 7 states from August 2022 to April 2023 to evaluate knowledge, attitudes, and practices and to assess homeless shelter/organizational characteristics.
Article Synopsis
- Drug prices significantly impact government budgets through direct spending on public programs like Medicare and Medicaid, and indirect costs via private insurance subsidies for public employees.
- The Senate parliamentarian's ruling prevents extending price controls from the Inflation Reduction Act to private insurers, arguing their costs don't affect the federal budget.
- In 2019, direct government spending on outpatient retail prescription drugs reached $154.85 billion, with indirect spending through private insurers totaling $53.59 billion, highlighting the substantial financial burden of drug costs on government entities.